Vitamin D deficiency

Classifications

Vitamin D deficiency is typically diagnosed by measuring the concentration of the 25-hydroxyvitamin D in the blood, which is the most accurate measure of stores of vitamin D in the body. One nanogram per millilitre () is equivalent to 2.5 nanomoles per litre ().

• Severe deficiency:
• Deficiency:
• Insufficient: =
• Normal: = Vitamin D levels falling within this normal range prevent clinical manifestations of vitamin D insufficiency as well as vitamin D toxicity.

Signs and symptoms

In most cases, vitamin D deficiency is almost asymptomatic. It may only be detected on blood tests but is the cause of some bone diseases and is associated with other conditions:

Complications

• Rickets, a childhood disease characterized by impeded growth and deformity of the long bones. The earliest sign of vitamin D deficiency is craniotabes, abnormal softening or thinning of the skull.

• Osteomalacia, a bone-thinning disorder that occurs exclusively in adults and is characterized by proximal muscle weakness and bone fragility. Women with vitamin D deficiency who have been through multiple pregnancies are at elevated risk of osteomalacia.

• Osteoporosis, a condition characterized by reduced bone mineral density and increased bone fragility

• Increased risk of fracture

• Myopathy: Muscle aches, weakness, and twitching (fasciculations) due to reduced blood calcium (hypocalcemia); impaired muscle glycogen metabolism (abnormal glycogen accumulation), atrophy of type II (fast-twitch/glycolytic) muscle fibres, and diminished calcium uptake by the sarcoplasmic reticulum (needed for muscle contraction).

• Periodontitis, local inflammatory bone loss that can result in tooth loss.

• Pre-eclampsia: There has been an association between vitamin D deficiency and women who develop pre-eclampsia in pregnancy. The exact relationship of these conditions is not well understood. Maternal vitamin D deficiency may affect the baby, causing overt bone disease from before birth and impairment of bone quality after birth.

• Respiratory infections and COVID-19: Vitamin D deficiency may increase the risk of severe acute respiratory infections and COPD. Emerging studies have suggested a link between vitamin D deficiency and COVID-19 symptoms. A review has shown that vitamin D deficiency is not associated with a higher chance of having COVID-19 but is associated with a greater severity of the disease, including 80% increases in the rates of hospitalization and mortality.

• Schizophrenia: Vitamin D deficiency is associated with the development of schizophrenia. People with schizophrenia generally have lower levels of vitamin D. The environmental risk factors of seasonality of birth, latitude, and migration linked to schizophrenia all implicate vitamin D deficiency, as do other health conditions such as maternal obesity. Vitamin D is essential for the normal development of the nervous system. Maternal vitamin D deficiency can cause prenatal neurodevelopmental defects, which influence neurotransmission, altering brain rhythms and the metabolism of dopamine. Vitamin D receptors, CYP27B1, and CYP24A1 are found in various regions of the brain, showing that vitamin D is a neuroactive, neurosteroid hormone essential for the development of the brain and normal function. Inflammation as a causative factor in schizophrenia is normally suppressed by vitamin D.

• Parkinson's disease: Many studies have confirmed the association between Parkinson's disease and low levels of vitamin D. Because vitamin D has neuroprotective functions, it is possible that vitamin D deficiency can cause Parkinson's disease, but firm conclusions remains uncertain.

Risk factors

Those most likely to be affected by vitamin D deficiency are people with little exposure to sunlight. Certain climates, dress habits, the avoidance of sun exposure, and the use of too much sunscreen protection can all limit the production of vitamin D.

Age

Elderly people have a higher risk of having a vitamin D deficiency due to a combination of several risk factors, including decreased sunlight exposure, decreased intake of vitamin D in the diet, and decreased skin thickness, which leads to further decreased absorption of vitamin D from sunlight.

Fat percentage

Since vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol) are fat-soluble, humans and other animals with a skeleton need to store some fat. Without fat, the animal will have a hard time absorbing vitamin D2 and vitamin D3, and the lower the fat percentage, the greater the risk of vitamin deficiency, which is the case in some athletes who strive to get as lean as possible.

Malnutrition

Although rickets and osteomalacia are now rare in Britain, osteomalacia outbreaks in some immigrant communities included women with seemingly adequate daylight outdoor exposure wearing typical Western clothing. Having darker skin and reduced exposure to sunshine did not produce rickets unless the diet deviated from a Western omnivore pattern characterized by high intakes of meat, fish, and eggs and low intakes of high-extraction cereals. In sunny countries where rickets occurs among older toddlers and children, rickets has been attributed to low dietary calcium intakes. This is characteristic of cereal-based diets with limited access to dairy products. Rickets was formerly a major public health problem among the US population; in Denver, almost two-thirds of 500 children had mild rickets in the late 1920s. An increase in the proportion of animal protein in the 20th-century American diet coupled with increased consumption of milk fortified with relatively small quantities of vitamin D coincided with a dramatic decline in the number of rickets cases. One study of children in a hospital in Uganda, however, showed no significant difference in vitamin D levels of malnourished children compared to non-malnourished children. Because both groups were at risk due to darker skin pigmentation, both groups had vitamin D deficiency. Nutritional status did not appear to play a role in this study.

Obesity

There is an increased risk of vitamin D deficiency in people who are considered overweight or obese based on their body mass index (BMI) measurement. The relationship between these conditions is not well understood. Different factors could contribute to this relationship, particularly diet, and sunlight exposure. Alternatively, vitamin D is fat-soluble, so excess amounts can be stored in fat tissue and used during winter when sun exposure is limited.

Sun exposure

The use of sunscreen with a sun protection factor of 8 can theoretically inhibit more than 95% of vitamin D production in the skin. In practice, however, sunscreen is applied so as to have a negligible effect on vitamin D status. Vitamin D sufficiency of those in Australia and New Zealand is unlikely to have been affected by campaigns advocating sunscreen. Instead, wearing clothing is more effective at reducing the amount of skin exposed to UVB and reducing natural vitamin D synthesis. Clothing that covers a large portion of the skin, when worn on a consistent and regular basis, such as the burqa, is correlated with lower vitamin D levels and an increased prevalence of vitamin D deficiency.

Regions far from the equator have a high seasonal variation of the amount and intensity of sunlight. In the UK, the prevalence of low vitamin D status in children and adolescents is found to be higher in winter than in summer. Lifestyle factors such as indoor versus outdoor work and time spent in outdoor recreation play an important role.

Additionally, vitamin D deficiency has been associated with urbanisation in terms of both air pollution, which blocks UV light, and an increase in the number of people working indoors. The elderly are generally exposed to less UV light due to hospitalisation, immobility, institutionalisation, and being housebound, leading to decreased levels of vitamin D.

Darker skin color

Because of melanin which enables natural sun protection, dark-skinned people are susceptible to vitamin D deficiency. Three to five times greater sun exposure is necessary for naturally darker skinned people to produce the same amount of vitamin D as those with light skin.

Malabsorption

Rates of vitamin D deficiency are higher among people with untreated celiac disease, inflammatory bowel disease, exocrine pancreatic insufficiency from cystic fibrosis, and short bowel syndrome,

Critical illness

Vitamin D deficiency is associated with increased mortality in critical illness. People who take vitamin D supplements before being admitted for intensive care are less likely to die than those who do not take vitamin D supplements. Vitamin D3 (cholecalciferol) or calcitriol given orally may reduce the mortality rate without significant adverse effects.

Breastfeeding

Infants who exclusively breastfeed need a vitamin D supplement, especially if they have dark skin or have minimal sun exposure. The American Academy of Pediatrics recommends that all breastfed infants receive (IU) per day of oral vitamin D.

Pathophysiology

Decreased exposure of the skin to sunlight is a common cause of vitamin D deficiency. People with a darker skin pigment with increased amounts of melanin may have decreased production of vitamin D. Melanin absorbs ultraviolet B radiation from the sun and reduces vitamin D production. Sunscreen can also reduce vitamin D production. Medications may speed up the metabolism of vitamin D, causing a deficiency.

The liver is required to transform vitamin D into 25-hydroxyvitamin D. This is an inactive metabolite of vitamin D but is a necessary precursor (building block) to create the active form of vitamin D.

The kidneys are responsible for converting 25-hydroxyvitamin D to 1,25-hydroxyvitamin D. This is the active form of vitamin D in the body. Kidney disease reduces 1,25-hydroxyvitamin D formation, leading to a deficiency of the effects of vitamin D.

Intestinal conditions that result in malabsorption of nutrients may also contribute to vitamin D deficiency by decreasing the amount of vitamin D absorbed via diet. In addition, a vitamin D deficiency may lead to decreased absorption of calcium by the intestines, resulting in increased production of osteoclasts that may break down a person's bone matrix.

Diagnosis

The serum concentration of calcifediol, also called 25-hydroxyvitamin D (abbreviated 25(OH)D), is typically used to determine vitamin D status. Most vitamin D is converted to 25(OH)D in the serum, giving an accurate picture of vitamin D status. The level of serum 1,25(OH)D (calcitriol) is not usually used to determine vitamin D status because it often is regulated by other hormones in the body such as parathyroid hormone. The levels of 1,25(OH)D can remain normal even when a person may be vitamin D deficient. Serum level of 25(OH)D is the laboratory test ordered to indicate whether or not a person has vitamin D deficiency or insufficiency. It is also considered reasonable to treat at-risk persons with vitamin D supplementation without checking the level of 25(OH)D in the serum, as vitamin D toxicity has only been rarely reported to occur.

Levels of 25(OH)D that are consistently above 200 nanograms per milliliter (ng/mL) (500 nanomoles per liter, nmol/L) are potentially toxic. Vitamin D toxicity usually results from taking supplements in excess. Hypercalcemia is often the cause of symptoms, and levels of 25(OH)D above 150 ng/mL (375 nmol/L) are usually found, although in some cases 25(OH)D levels may appear to be normal. Periodic measurement of serum calcium in individuals receiving large doses of vitamin D is recommended.

Screening

The official recommendation from the United States Preventive Services Task Force is that for persons that do not fall within an at-risk population and are asymptomatic, there is not enough evidence to prove that there is any benefit in screening for vitamin D deficiency.

Treatment

UVB exposure

Vitamin D overdose is impossible from UV exposure: the skin reaches an equilibrium where the vitamin degrades as fast as it is created.

Sun tanning

Light therapy

Main article: Light therapy#Vitamin D deficiency

Exposure to photons (light) at specific wavelengths of narrowband UVB enables the body to produce vitamin D to treat vitamin D deficiency.

Supplement

In the United States, the Food and Nutrition Board at the National Academies of Sciences, Engineering, and Medicine has established Recommended Dietary Allowances and Adequate Intakes for vitamin D. These values range from 15 to 20 mcg (600–800 IU) for adults and from 10 to 15 mcg (400–600 IU) for infants, children, and adolescents, depending on age. The Canadian Paediatric Society recommends that pregnant or breastfeeding women consider taking 2000 IU/day, that all babies who are exclusively breastfed receive a supplement of , and that babies living north of 55°N get from October to April.

Treating vitamin D deficiency depends on the severity of the deficit. Treatment involves an initial high-dosage treatment phase until the required serum levels are reached, followed by the maintenance of the acquired levels. The lower the 25(OH)D serum concentration is before treatment, the higher the dosage that is needed to quickly reach an acceptable serum level.

The initial high-dosage treatment can be given on a daily or weekly basis or can be given in form of one or several single doses (also known as stoss therapy, from the German word Stoß, meaning "push").

Therapy prescriptions vary, and there is no consensus yet on how best to arrive at an optimum serum level. While there is evidence that vitamin D3 raises 25(OH)D blood levels more effectively than vitamin D2, other evidence indicates that D2 and D3 are equal for maintaining 25(OH)D status.

Initial phase

Daily, weekly, or monthly dose

For treating rickets, the American Academy of Pediatrics (AAP) has recommended that pediatric patients receive an initial two to three months of treatment with "high-dose" vitamin D therapy. In this regime, the daily dose of cholecalciferol is for newborns, for 1- to 12-month-old infants, and for patients over 1 year of age.

For adults, other dosages have been called for. A review of 2008/2009 recommended dosages of cholecalciferol per required serum increase, to be given daily over two to three months. In another proposed cholecalciferol loading dose guideline for vitamin D-deficient adults, a weekly dosage is given, up to a total amount that is proportional to the required serum increase (up to the level of ) and within certain bodyweight limits, to body weight.

According to new data and practices relevant to vitamin D levels in the general population in France, to establish optimal vitamin D status and frequency of intermittent supplement dosing, patients with or at high risk for osteoporosis and vitamin D deficiency should start supplementation with a loading phase consisting of weekly of vitamin D for eight weeks in patients with levels

There are no consistent data suggesting the ideal regimen of supplementation with vitamin D, and the question of the ideal time between doses is still of debate. Ish-Shalom et al. performed a study in elderly women to compare the efficacy and safety of a daily dose of to a weekly dose of and to a dose of given every 28 days for two months. They concluded that supplementation with vitamin D can be equally achieved with daily, weekly, or monthly dosing frequencies. Another study comparing daily, weekly, and monthly supplementation of vitamin D in deficient patients was published by Takacs et al. They reported equal efficacy of taken daily, taken weekly, and taken monthly. Nevertheless, these consistent findings differ from the report by Chel et al., in which a daily dose was more effective than a monthly dose. In that study, the compliance calculation could be questionable since only random samples of the returned medications were counted. In a study by De Niet et al., 60 subjects with vitamin D deficiency were randomized to receive vitamin D3 daily or monthly. They reported a similar efficacy of the two dosing frequencies, with the monthly dose providing more rapid normalization of vitamin D levels.

Single-dose therapy

Alternatively, a single-dose therapy is used for instance if there are concerns regarding the patient's compliance. The single-dose therapy can be given as an injection but is normally given in the form of oral medication.

Vitamin D doses and meals

The presence of a meal and the fat content of that meal may also be important. Because vitamin D is fat-soluble, it is hypothesized that absorption would be improved if patients are instructed to take their supplement with a meal. Raimundo et al. performed different studies confirming that a high-fat meal increased the absorption of vitamin D3 as measured by serum 25(OH) D. A clinical report indicated that serum 25(OH) D levels increased by an average of 57% over a 2-month to 3-month period in 17 clinic patients after they were instructed to take their usual dose of vitamin D with the largest meal of the day.

Another study conducted in 152 healthy men and women concluded that diets rich in monounsaturated fatty acids may improve and those rich in polyunsaturated fatty acids may reduce the effectiveness of vitamin D3 supplements. In another study performed by Cavalier E. et al., 88 subjects received orally a single dose of of vitamin D3 solubilized in an oily solution as two ampoules each containing (D‐CURE®, Laboratories SMB SA, Brussels, Belgium) with or without a standardized high‐fat breakfast. No significant difference between fasting vs. fed conditions was observed.

Maintenance phase

Once the desired serum level has been achieved, be it by a high daily or weekly or monthly dose or by a single-dose therapy, the AAP recommendation calls for a maintenance supplementation of for all age groups, with this dosage being doubled for premature infants, dark-skinned infants and children, children who reside in areas of limited sun exposure (37.5° latitude), obese patients, and those on certain medications.

Special cases

To maintain blood levels of calcium, therapeutic vitamin D doses are sometimes administered (up to or daily) to patients who have had their parathyroid glands removed (most commonly kidney dialysis patients who have had tertiary hyperparathyroidism, but also to patients with primary hyperparathyroidism) or with hypoparathyroidism. Patients with chronic liver disease or intestinal malabsorption disorders may also require larger doses of vitamin D (up to , or , daily).

Co-supplementation with vitamin K

The combination of vitamin D and vitamin K supplements has been shown in trials to improve bone quality. As high intake of vitamin D is a cause of raised calcium levels (hypercalcemia), the addition of vitamin K may be beneficial in helping to prevent vascular calcification, particularly in people with chronic kidney disease.

Epidemiology

The estimated percentage of the population with a vitamin D deficiency varies based on the threshold used to define a deficiency.

Recommendations for 25(OH)D serum levels vary across authorities, and probably vary based on factors like age; calculations for the epidemiology of vitamin D deficiency depend on the recommended level used.

A 2011 Institute of Medicine (IOM) report set the sufficiency level at (), while in the same year The Endocrine Society defined sufficient serum levels at and others have set the level as high as .

Applying the IOM standard to NHANES data on serum levels, for the period from 1988 to 1994 22% of the US population was deficient, and 36% were deficient for the period between 2001 and 2004; applying the Endocrine Society standard, 55% of the US population was deficient between 1988 and 1994, and 77% were deficient for the period between 2001 and 2004.

In 2011 the Centers for Disease Control and Prevention applied the IOM standard to NHANES data on serum levels collected between 2001 and 2006 and determined that 32% of Americans were deficient during that period (8% at risk of deficiency, and 24% at risk of inadequacy).

History

The role of diet in the development of rickets was determined by Edward Mellanby between 1918 and 1920. In 1921, Elmer McCollum identified an antirachitic substance found in certain fats that could prevent rickets. Because the newly discovered substance was the fourth vitamin identified, it was called vitamin D. The 1928 Nobel Prize in Chemistry was awarded to Adolf Windaus, who discovered the steroid 7-dehydrocholesterol, the precursor of vitamin D. Potential anticancer roles of the vitamin D metabolite calcifediol were observed epidemiologically by Frank Garland and Cedric Garland in the 1980s which were later observed clinically by Michael F. Holick and Raphael E. Cuomo.

Before the fortification of milk products with vitamin D, rickets was a major public health problem. In the United States, milk has been fortified with 10 micrograms (400 IU) of vitamin D per quart since the 1930s, leading to a dramatic decline in the number of rickets cases.

Research

Some evidence suggests vitamin D deficiency may be associated with a worse outcome for some cancers, but evidence is insufficient to recommend that vitamin D be prescribed for people with cancer. Taking vitamin D supplements has no significant effect on cancer risk. Vitamin D3, however, appears to decrease the risk of death from cancer but concerns with the quality of the data exist. Nevertheless, studies suggest that Vitamin D deficiency is associated with increased risk of development melanoma. Low levels of 25-hydroxyvitamin D, a routinely used marker for vitamin D, have been suggested as a contributing factor in increasing the risk the development and progression of various types of cancer. Vitamin D requires activation by cytochrome P450 (CYP) enzymes to become active and bind to the VDR. Specifically, CYP27A1, CYP27B1, and CYP2R1 are involved in the activation of vitamin D, while CYP24A1 and CYP3A4 are responsible for the degradation of the active vitamin D. CYP24A1, the primary catabolic enzyme of calcitriol, is overexpressed in melanoma tissues and cells. This overexpression could lead to lower levels of active vitamin D in tissues, potentially promoting the development and progression of melanoma. Several drug classes and natural health products can modulate vitamin D-related CYP enzymes, potentially causing lower levels of vitamin D and its active metabolites in tissues, suggesting that maintaining adequate vitamin D levels, that is, avoiding vitamin D deficiency, either through dietary supplements or by modulating CYP metabolism, could be beneficial in decreasing the risk of melanoma development.

Vitamin D deficiency is thought to play a role in the pathogenesis of non-alcoholic fatty liver disease.

Evidence suggests that vitamin D deficiency may be associated with impaired immune function. Those with vitamin D deficiency may have trouble fighting off certain types of infections. It has also been thought to correlate with cardiovascular disease, type 1 diabetes, type 2 diabetes, and some cancers.

Review studies have also seen associations between vitamin D deficiency and pre-eclampsia.

References

References

1. "Office of Dietary Supplements - Vitamin D".
2. (20 January 2020). "Vitamin D deficiency 2.0: an update on the current status worldwide.". European Journal of Clinical Nutrition.
3. (April 2008). "Vitamin D deficiency: a worldwide problem with health consequences". The American Journal of Clinical Nutrition.
4. {{MerckManual. 01. 004. k. BABBBEAE. Vitamin D
5. (December 2004). "Functional indices of vitamin D status and ramifications of vitamin D deficiency". The American Journal of Clinical Nutrition.
6. (February 2014). "Vitamin D deficiency in India: prevalence, causalities and interventions". Nutrients.
7. (2021). "Vitamin D Deficiency". StatPearls Publishing.
8. (September 2016). "The Return of Congenital Rickets, Are We Missing Occult Cases?". Calcified Tissue International.
9. (May 2008). "Craniotabes in normal newborns: the earliest sign of subclinical vitamin D deficiency". The Journal of Clinical Endocrinology & Metabolism.
10. Bender, David A.. "Nutritional Biochemistry of the Vitamins". Cambridge University Press.
11. (April 2008). "Hypovitaminosis D: a widespread epidemic". Geriatrics.
12. (February 2013). "Vitamin D and bone health in childhood and adolescence". Calcified Tissue International.
13. (October 2008). "Vitamin D: a D-Lightful health perspective". Nutrition Reviews.
14. (2014). "The role of vitamin D in skeletal and cardiac muscle function". Frontiers in Physiology.
15. (December 2016). "Osteoporosis and Periodontitis". Current Osteoporosis Reports.
16. (15 September 2015). "Comparison of Vitamin D levels in cases with preeclampsia, eclampsia and healthy pregnant women". International Journal of Clinical and Experimental Medicine.
17. (October 2015). "Congenital rickets due to vitamin D deficiency in the mothers". Clinical Nutrition.
18. (February 2017). "Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data". BMJ.
19. (April 2019). "Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials". Thorax.
20. (7 October 2020). "Vitamin D deficiency increased risk of COVID in healthcare workers, new UK study shows". [[University of Birmingham]].
21. Busby, Mattha. (10 January 2021). "Does vitamin D combat Covid?".
22. (12 August 2021). "Addendum to vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis". Critical Reviews in Food Science and Nutrition.
23. (February 2016). "Vitamin D in schizophrenia: a clinical review". Evidence-Based Mental Health.
24. (1 February 2018). "Vitamin D deficiency: infertility and neurodevelopmental diseases (attention deficit hyperactivity disorder, autism, and schizophrenia)". American Journal of Physiology. Cell Physiology.
25. (5 February 2020). "Maternal Obesity as a Risk Factor for Brain Development and Mental Health in the Offspring". Neuroscience.
26. Pignolo, A., Mastrilli, S., Davì, C., Arnao, V., Aridon, P., Dos Santos Mendes, F. A., Gagliardo, C., & D'Amelio, M.. (14 March 2022). "Vitamin D and Parkinson's Disease.". Nutrients.
27. Kennel, Kurt, MD et al., [http://www.mayoclinicproceedings.org/article/S0025-6196(11)60190-0/abstract Vitamin D Deficiency in Adults: When to Test and How to Treat], Mayo Clinic Proceedings, August 2010, pp752–758
28. (April 2002). "Vitamin D deficiency, muscle function, and falls in elderly people". The American Journal of Clinical Nutrition.
29. Fetters, K. Aleisha. (19 January 2023). "15 Negative Effects of Having a Low Body-fat Percentage". Men's Journal.
30. (November 1997). "An epidemiological model of privational rickets and osteomalacia". The Proceedings of the Nutrition Society.
31. (January 1981). "The role of cereals in the aetiology of nutritional rickets: the lesson of the Irish National Nutrition Survey 1943-8". The British Journal of Nutrition.
32. (1989). "The problem of rickets in UK Asians". Journal of Human Nutrition and Dietetics.
33. (December 2004). "Nutritional rickets: deficiency of vitamin D, calcium, or both?". The American Journal of Clinical Nutrition.
34. (November 1967). "A history of rickets in the United States". The American Journal of Clinical Nutrition.
35. Garrison, R., Jr., Somer, E., The nutrition desk reference(1997)
36. DuPuis, E. Melanie. (January 2015). "Nature's Perfect Food: How Milk Became America's Drink". NYU Press.
37. (September 2015). "Serum vitamin D status in children with protein-energy malnutrition admitted to a national referral hospital in Uganda". BMC Research Notes.
38. (April 2015). "Obesity and vitamin D deficiency: a systematic review and meta-analysis". Obesity Reviews.
39. (October 2007). "The effects of vitamin D deficiency and insufficiency on the endocrine and paracrine systems". Biological Research for Nursing.
40. (October 2009). "Does chronic sunscreen use reduce vitamin D production to insufficient levels?". The British Journal of Dermatology.
41. (August 2002). "Vitamin D intake and vitamin D status of Australians". The Medical Journal of Australia.
42. (September 2010). "Vitamin D and hip fractures: Indian scenario". The Journal of the Association of Physicians of India.
43. (April 2007). "Vitamin D in childhood and adolescence". Postgraduate Medical Journal.
44. (November 2009). "Global vitamin D status and determinants of hypovitaminosis D". Osteoporosis International.
45. (2012). "Vitamin D: The "sunshine" vitamin". Journal of Pharmacology & Pharmacotherapeutics.
46. (December 2013). "Appropriate nutrient supplementation in celiac disease". Annals of Medicine.
47. (November 2015). "Vitamin D deficiency in patients with intestinal malabsorption syndromes--think in and outside the gut". Journal of Digestive Diseases.
48. (April 2016). "Guidelines on vitamin D replacement in bariatric surgery: Identification and systematic appraisal". Metabolism.
49. (January 2014). "Vitamin D supplementation for prevention of mortality in adults". The Cochrane Database of Systematic Reviews.
50. (April 2017). "Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials". Journal of Critical Care.
51. (19 September 2016). "Vitamin D: On the double". American Academy of Pediatrics.
52. (August 2008). "The use of calcium and vitamin D in the management of osteoporosis". Therapeutics and Clinical Risk Management.
53. (August 2010). "Vitamin D deficiency in adults: when to test and how to treat". Mayo Clinic Proceedings.
54. (September 2011). "Assessing vitamin D status". Current Opinion in Clinical Nutrition and Metabolic Care.
55. (September 2013). "Vitamin D: deficiency, sufficiency and toxicity". Nutrients.
56. "Final Recommendation Statement: Vitamin D Deficiency: Screening - US Preventive Services Task Force".
57. (July 2007). "Vitamin D deficiency". The New England Journal of Medicine.
58. (February 2002). "Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health". Current Opinion in Endocrinology, Diabetes and Obesity.
59. (24 January 2014). "UVB phototherapy and skin cancer risk: a review of the literature". Int. J. Dermatol..
60. "Office of Dietary Supplements - Vitamin D".
61. "Vitamin D supplementation: Recommendations for Canadian mothers and infants". Canadian Paediatric Society.
62. (July 2011). "Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline". The Journal of Clinical Endocrinology & Metabolism.
63. (October 2013). "A review on vitamin d deficiency treatment in pediatric patients". The Journal of Pediatric Pharmacology and Therapeutics.
64. (June 2012). "Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis". The American Journal of Clinical Nutrition.
65. (October 2008). "Vitamin D: a rapid review". Dermatology Nursing.
66. (April 2010). "Cholecalciferol loading dose guideline for vitamin D-deficient adults". European Journal of Endocrinology.
67. (2019). "Vitamin D supplementation in France in patients with or at risk for osteoporosis: recent data and new practices.". Joint Bone Spine.
68. (2008). "Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients.". The Journal of Clinical Endocrinology & Metabolism.
69. (2016). "Randomized clinical trial to comparing the efficacy of daily, weekly and monthly administration of vitamin D3.". Endocrine.
70. (2008). "Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents.". Osteoporos. Int..
71. (2018). "A Randomized study to compare a monthly to a daily Administration of Vitamin D₃ Supplementation.". Nutrients.
72. (2011). "Effect of high- versus low-fat meal on serum 25-hydroxyvitamin D levels after a single dose of vitamin D: a single-blind, parallel, randomized trial.". International Journal of Endocrinology.
73. (2015). "Effect of fat on serum 25-hydroxyvitamin D3 levels after a single oral dose of vitamin D in young healthy adults: a double-blind randomized placebo-controlled study.". Eur J Nutr.
74. (2010). "Taking Vitamin D With the Largest Meal Improves Absorption and Results in Higher Serum Levels of 25-Hydroxyvitamin D3.". Journal of Bone and Mineral Research.
75. (2011). "Type of dietary fat is associated with the 25-hydroxyvitaminD increment in response to vitamin D supplementation.". The Journal of Clinical Endocrinology & Metabolism.
76. (2016). "A Randomised, Cross-Over Study to Estimate the Influence of Food on the 25-Hydroxyvitamin D3 Serum Level after Vitamin D3 Supplementation.". Nutrients.
77. (November 2005). "The vitamin D epidemic and its health consequences". The Journal of Nutrition.
78. (April 2020). "The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials". Food & Function.
79. (October 2020). "Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health". Maturitas.
80. (October 2020). "Vitamin K deficiency: an emerging player in the pathogenesis of vascular calcification and an iatrogenic consequence of therapies in advanced renal disease". American Journal of Physiology. Renal Physiology.
81. (April 2014). "Vitamin D and risk of cause-specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies". BMJ.
82. (March 2009). "Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004". Archives of Internal Medicine.
83. (11 February 2016). "Vitamin D". NIH Office of Dietary Supplements.
84. (2011). "Dietary Reference Intakes for Calcium and Vitamin D". National Academies Press.
85. (19 October 2016). "The risks and benefits of sun exposure 2016". Dermato-Endocrinology.
86. (March 2011). "Vitamin D Status: United States, 2001–2006". CDC NCHS Data Brief.
87. (August 2003). "Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective". Pediatrics.
88. Maugh II, Thomas H. [https://www.latimes.com/la-me-frank-garland-20100831-story.html "Frank C. Garland dies at 60; epidemiologist helped show importance of vitamin D: Garland and his brother Cedric were the first to demonstrate that vitamin D deficiencies play a role in cancer and other diseases."], ''[[Los Angeles Times]]'', August 31, 2010. Accessed September 4, 2010.
89. (1980). "Do sunlight and vitamin D reduce the likelihood of colon cancer?". International Journal of Epidemiology.
90. (2006). "Vitamin D: its role in cancer prevention and treatment". Progress in Biophysics and Molecular Biology.
91. (2024). "Serum 25-Hydroxyvitamin D and Five-Year Survival in Primary Colon Cancer: A Retrospective Cohort Study". Nutrition and Cancer.
92. (December 2004). "Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease". The American Journal of Clinical Nutrition.
93. (2011). "Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review". The Oncologist.
94. (April 2014). "The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis". The Lancet. Diabetes & Endocrinology.
95. (January 2014). "Vitamin D supplementation for prevention of mortality in adults". The Cochrane Database of Systematic Reviews.
96. (April 2024). "Vitamin D in Melanoma: Potential Role of Cytochrome P450 Enzymes". Life.
97. (August 2013). "Meta-analysis: vitamin D and non-alcoholic fatty liver disease". Alimentary Pharmacology & Therapeutics.
98. (2015). "Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis". International Journal of Clinical and Experimental Medicine.
99. (2013). "Vitamin D and immune function". Nutrients.
100. (13 September 2022). "Does Vitamin D Prevent Autoimmune Disease? {{!}} Science-Based Medicine".
101. (April 2018). "Association of vitamin D level and vitamin D deficiency with risk of preeclampsia: A systematic review and updated meta-analysis". Taiwanese Journal of Obstetrics & Gynecology.